form8k.htm


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 
 
 

FORM 8-K

 

 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  APRIL 28, 2009
 
Commission File Number:  0-24260

 

 
 

AMEDISYS, INC.
(Exact Name of Registrant as specified in its Charter)

 
 

 
  

     
Delaware
 
11-3131700
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)

5959 S. Sherwood Forest Blvd., Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)

(225) 292-2031 or (800) 467-2662
(Registrant’s telephone number, including area code)



(Former name or former address, if changed since last report)



 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Information to be included in the report
 


 
 

 
 
Section 2 — Financial Information
 
Item 2.02.   Results of Operations and Financial Condition
 
On April 28, 2009, Amedisys, Inc. (“we,” “us,” “our” or the “Company”) issued a press release announcing its earnings for the three-month period ended March 31, 2009. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
 
 
The information presented in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, unless we specifically state that the information is to be considered “filed” under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Exchange Act of 1933, as amended, or the Exchange Act.
 
Section 7 – Regulation FD
 
Item 7.01. Regulation FD Disclosure
 
Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference.
 
The information presented in Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, unless we specifically state that the information is to be considered “filed” under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
 
Section 9 – Financial Statements and Exhibits
 
Item 9.01. Financial Statements and Exhibits
 
(d) Exhibits.
 
         
   
99.1
  
 

2

Signatures
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
     
AMEDISYS, INC.
(Registrant)
   
By:
 
/s/ Dale E. Redman
 
   
Dale E. Redman
   
Chief Financial Officer and Duly Authorized Officer
 
DATE: April 28, 2009
 
3

Exhibit Index
 
 
 
     
Exhibit No.
 
 
Description
99.1
 
 

 
4